REXAHN PHARMACEUTICALS, INC. 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Mar 21, 2016
Insider Transaction Report
Form 4
Suzdak Peter David
Chief Executive Officer
Transactions
- Award
Common Stock
2016-03-18$0.32/sh+60,000$19,386→ 60,000 total
Footnotes (1)
- [F1]The price of $0.3231 per share represents a weighted average of purchase prices ranging from $0.3216 to $0.3244 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.